9 research outputs found
Clinical pathways and management of antithrombotic therapy in patients with acute coronary syndrome (ACS): a Consensus Document from the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Society of Emergency Medicine (SIMEU) and Italian Society of Interventional Cardiology (SICI-GISE)
No full textDouble-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial.
No full textIn patients undergoing PCI for acute coronary syndromes, a 7-day double-dose clopidogrel regimen was associated with a reduction in cardiovascular events and stent thrombosis compared with the standard dose. Effi cacy and safety did not diff er between high-dose and low-dose aspirin. A double-dose clopidogrel regimen can be considered for all patients with acute coronary syndromes treated with an early invasive strategy and intended early PCI
Adjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
No full textAdjuvant antithrombotic therapy in ST-elevation myocardial infarction: A narrative review
No full textOptimising pharmacotherapy for secondary prevention of nonâinvasively managed acute coronary syndrome
No full textExpert consensus document on the use of antiplatelet agents: 2010 update.
No full textItem does not contain fulltex
